NM_000535.7:c.1714_1717delGCAAinsACAT
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM1
The NM_000535.7(PMS2):c.1714_1717delGCAAinsACAT(p.AlaThr572ThrSer) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. It is difficult to determine the true allele frequency of this variant because it is of type MNV, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A572A) has been classified as Likely benign.
Frequency
Consequence
NM_000535.7 missense
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Lynch syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- mismatch repair cancer syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- ovarian cancerInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- Muir-Torre syndromeInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000535.7. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PMS2 | NM_000535.7 | MANE Select | c.1714_1717delGCAAinsACAT | p.AlaThr572ThrSer | missense | N/A | NP_000526.2 | ||
| PMS2 | NM_001406866.1 | c.1900_1903delGCAAinsACAT | p.AlaThr634ThrSer | missense | N/A | NP_001393795.1 | |||
| PMS2 | NM_001322014.2 | c.1714_1717delGCAAinsACAT | p.AlaThr572ThrSer | missense | N/A | NP_001308943.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PMS2 | ENST00000265849.12 | TSL:1 MANE Select | c.1714_1717delGCAAinsACAT | p.AlaThr572ThrSer | missense | N/A | ENSP00000265849.7 | ||
| PMS2 | ENST00000382321.5 | TSL:1 | c.804-4060_804-4057delGCAAinsACAT | intron | N/A | ENSP00000371758.4 | |||
| PMS2 | ENST00000406569.8 | TSL:1 | n.1678+36_1678+39delGCAAinsACAT | intron | N/A | ENSP00000514464.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Lynch syndrome 4;C5436817:Mismatch repair cancer syndrome 4 Uncertain:2
not specified Uncertain:1
Variant summary: PMS2 c.1714_1717delinsACAT (p.Ala572_Thr573delinsThrSer) results in an in-frame deletion-insertion that is predicted to delete/insert 2 amino acids from the protein. The frequency of this variant in the general population could not be determined as the technology used for large population databases (ExAC, gnomAD, ESP, 1000G) cannot detect variants of this type. Nevertheless, the constituent variants of this deletion-insertion variant (i.e. c.1714G>A/p.Ala572Thr and c.1717A>T/p.Thr573Ser), are found to co-occur (and are likely part of the same haplotype) in at least some individuals in gnomAD v2.1.1, with the allele frequency being lower than the estimated maximal expected allele frequency for pathogenic variant in PMS2 causing Lynch Syncdrome phenotype (0.00011). However, control population data need to be cautiously considered since the variants lie within a region of the PMS2 gene that has high pseudogene homology. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1714G>A and c.1717A>T have been reported to co-occur in one individual affected with Lynch Syndrome (Yurgelun_2015). These report(s) do not provide unequivocal conclusions about association of the variant with Lynch Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three ClinVar submitters (evaluation after 2014) cite the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.
not provided Uncertain:1
In-frame deletion of 2 amino acids that are replaced by 2 different amino acids in a non-repeat region; In silico analysis indicates that this variant does not alter protein structure/function; Reported in an individual undergoing multigene cancer panel testing due to a history of a Lynch-related cancer and/or polyps (PMID: 25980754); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 17016615, 25980754)
Hereditary nonpolyposis colorectal neoplasms Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at